GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Net Income From Continuing Operations

Epigral (BOM:543332) Net Income From Continuing Operations : ₹1,958 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Epigral's net income from continuing operations for the three months ended in Mar. 2024 was ₹772 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,958 Mil.

Epigral Net Income From Continuing Operations Historical Data

The historical data trend for Epigral's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Net Income From Continuing Operations Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
Get a 7-Day Free Trial 1,409.93 1,608.58 3,834.22 5,225.26 2,906.72

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 767.33 315.07 379.96 490.84 772.29

Epigral Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,958 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epigral (BOM:543332) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:506222 BOM:500339 BOM:530001 BOM:500052 BOM:500150 BOM:500201 BOM:500171 BOM:500117 BOM:506618 BOM:500199 SAU:2010 TSE:4063 XTER:BAS DOW XKRX:051910 SZSE:002493 SHSE:600989 CE XKLS:5183 XKRX:086520
Traded in Other Exchanges
EPIGRAL:India
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Website
https://www.meghmanifinechem.com
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines